NCT03662295|Completed
Loading search results
Sponsor study identifier
observational
1
1 country
1
Study Start
September 3, 2018
Actual (reported)Primary Completion
November 13, 2019
Actual (reported)Study Completion
November 13, 2019
Actual (reported)Stroke-like migraine attacks after radiation therapy-also known as SMART syndrome-constitute a rare condition typically characterized by headache, seizures, vision abnormalities, hemiparesis, and aphasia. The condition usually resolves within a few days or weeks of onset with no residual impairments. However, resolution in some cases extends over a period of months rather than weeks and may be incomplete. The purpose of this case report is to provide an in-depth description of the progression of changes in cognitive and language functioning for a person exhibiting SMART syndrome characterized by slow recovery.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 13, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 3, 2018
Actual (reported)September 3, 2018
Actual (reported)September 7, 2018
Actual (reported)November 13, 2019
Actual (reported)November 13, 2019
Actual (reported)Standardized assessment
Aphasia Quotient of the Western Aphasia Battery - Revised
Change from baseline at 6 months
Spoken picture description
Change from baseline at 6 weeks, 10 weeks, 14 weeks, 20 weeks, and 26 weeks
Written picture description
Change from baseline at 6 weeks, 10 weeks, 14 weeks, 20 weeks, and 26 weeks
Individual speech-language therapy sessions totaling 1.5 to 2.5 hours five days per week. Intervention activities include performing oral and written confrontation and responsive naming, writing single words to dictation, reading single words and sentences aloud, and generating written and spoken picture descriptions.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
One adult with SMART syndrome will participate in this study. The person will have cognitive and language deficits typical of those exhibited by people with SMART syndrome. Given the rarity of the disorder, only one participant is anticipated.
Quality Living, Inc.
Omaha, Nebraska, 68104, United States
Karen Hux, Ph.D.
Quality Living, Inc., Omaha, Nebraska
1 participants (actual enrollment reported by the registry).
First Submitted
September 3, 2018
First Posted
September 7, 2018
Study Start
September 3, 2018
Actual (reported)Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)
Vagus Nerve Stimulation and Stress Reduction Training for Migraine
Contact the study team to confirm eligibility.
Primary Completion
November 13, 2019
Actual (reported)Study Completion
November 13, 2019
Actual (reported)Last Updated
March 10, 2021
Record last verified: 2021-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: